3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Glioblastoma
23
Breast Neoplasms
22
Carcinoma, Non-Small-Cell Lung
17
Rectal Neoplasms
13
Prostatic Neoplasms
13
Gliosarcoma
12
Lung Neoplasms
10
Head and Neck Neoplasms
10
Esophageal Neoplasms
10
Brain Neoplasms
10
Neoplasms
9
Uterine Cervical Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
8
Adenocarcinoma Of Esophagus
8
Sarcoma
7
Neoplasm Metastasis
7
Central Nervous System Neoplasms
7
Pancreatic Neoplasms
6
Melanoma
6
Glioma
6
Carcinoma, Squamous Cell
6
Astrocytoma
6
Urinary Bladder Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Burkitt Lymphoma
5
Oropharyngeal Neoplasms
4
Medulloblastoma
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myeloid, Acute
4
Interventions
human papillomavirus vaccine, L1 type 16, 18
30
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
20
Papillomavirus Vaccines
9
Radiotherapy, Intensity-Modulated
4
Cisplatin
4
Blood Specimen Collection
4
fludarabine
3
Vaccines, Synthetic
3
Engerix-B
3
Cyclophosphamide
3
halofantrine
2
fludarabine phosphate
2
aldesleukin
2
Watchful Waiting
2
Vaccines
2
Patient Navigation
2
Paclitaxel
2
Light Coagulation
2
Interleukin-2
2
Imiquimod
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Hepatitis A Vaccines
2
Fluorouracil
2
Electrocoagulation
2
Cetuximab
2
Carboplatin
2
Albumin-Bound Paclitaxel
2
utomilumab
1
polyphenon E
1
infigratinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Papillomavirus Infections
×
Radiation
×
Clear all
NCT02258659
2024-09-24
OPTIMA
University of Chicago
Phase 2
Completed
62 enrolled
13 charts